Position in DXCM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,200,269
+$537,361 QoQ
Shares Held
47,517
+12.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#327
of 971 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $192,998,899 across 51 Medical Devices names. DXCM ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
509,302 | $46,214,063 | |
| 2 | STE |
STERIS plc
|
209,519 | $44,118,415 | |
| 3 | SYK |
Stryker Corp
|
138,667 | $43,657,918 | |
| 4 | MDT |
Medtronic plc
|
258,603 | $20,230,512 | |
| 5 | EW |
Edwards Lifesciences Corp
|
60,926 | $5,511,365 | |
| 6 | BSX |
Boston Scientific Corp
|
123,736 | $5,281,052 | |
| 7 | DXCM |
Dexcom Inc
This page
|
47,517 | $3,200,269 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
47,861 | $3,063,582 |
All Filings in DXCM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,200,269 | 47,517 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,662,908 | 42,403 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,749,775 | 41,431 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,851,686 | 27,518 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,901,083 | 33,235 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,019,608 | 29,574 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,189,381 | 28,152 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,545,339 | 23,051 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,497,648 | 22,029 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $3,089,681 | 22,276 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,504,632 | 44,360 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,506,120 | 37,579 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,458,846 | 26,915 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,294,438 | 19,749 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,276,690 | 20,105 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,531,387 | 19,014 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,103,714 | 14,809 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $2,145,138 | 4,193 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,713,407 | 3,191 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,672,844 | 3,059 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,656,333 | 3,879 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,523,813 | 4,240 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $747,943 | 2,023 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $742,014 | 1,800 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $641,748 | 1,583 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $372,669 | 1,384 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||